Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert T Gacerez

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Gene Therapy|March 9, 2018
T-bet promotes potent antitumor activity of CD4<sup>+</sup> CAR T cellsAlbert T Gacerez, Charles L Sentman
Journal of Cellular Physiology|May 11, 2016
How Chimeric Antigen Receptor Design Affects Adoptive T Cell TherapyAlbert T Gacerez, Benjamine Arellano, Charles L Sentman
Cancer Immunology, Immunotherapy : CII|February 18, 2018
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expressionAlbert T Gacerez, Casey K Hua, Margaret E Ackerman, et al.
Protein Engineering, Design & Selection : PEDS|October 18, 2017
Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6Casey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Elife|December 5, 2017
Computationally-driven identification of antibody epitopesCasey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor ImmunityMing-Ru Wu, Tong Zhang, Albert T Gacerez, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Gene Therapy|March 9, 2018
T-bet promotes potent antitumor activity of CD4<sup>+</sup> CAR T cellsAlbert T Gacerez, Charles L Sentman
Journal of Cellular Physiology|May 11, 2016
How Chimeric Antigen Receptor Design Affects Adoptive T Cell TherapyAlbert T Gacerez, Benjamine Arellano, Charles L Sentman
Cancer Immunology, Immunotherapy : CII|February 18, 2018
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expressionAlbert T Gacerez, Casey K Hua, Margaret E Ackerman, et al.
Protein Engineering, Design & Selection : PEDS|October 18, 2017
Development of unique cytotoxic chimeric antigen receptors based on human scFv targeting B7H6Casey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Elife|December 5, 2017
Computationally-driven identification of antibody epitopesCasey K Hua, Albert T Gacerez, Charles L Sentman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor ImmunityMing-Ru Wu, Tong Zhang, Albert T Gacerez, et al.
Pageof 1